Cargando…
Re: Aducanumab-Related ARIA: Paean or Lament?
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10184812/ https://www.ncbi.nlm.nih.gov/pubmed/36724162 http://dx.doi.org/10.1097/RLU.0000000000004509 |
_version_ | 1785042214970195968 |
---|---|
author | Høilund-Carlsen, Poul F. Alavi, Abass Revheim, Mona-Elisabeth |
author_facet | Høilund-Carlsen, Poul F. Alavi, Abass Revheim, Mona-Elisabeth |
author_sort | Høilund-Carlsen, Poul F. |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-10184812 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-101848122023-05-16 Re: Aducanumab-Related ARIA: Paean or Lament? Høilund-Carlsen, Poul F. Alavi, Abass Revheim, Mona-Elisabeth Clin Nucl Med Letter to the Editor Lippincott Williams & Wilkins 2023-06 2023-02-01 /pmc/articles/PMC10184812/ /pubmed/36724162 http://dx.doi.org/10.1097/RLU.0000000000004509 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) , where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. |
spellingShingle | Letter to the Editor Høilund-Carlsen, Poul F. Alavi, Abass Revheim, Mona-Elisabeth Re: Aducanumab-Related ARIA: Paean or Lament? |
title | Re: Aducanumab-Related ARIA: Paean or Lament? |
title_full | Re: Aducanumab-Related ARIA: Paean or Lament? |
title_fullStr | Re: Aducanumab-Related ARIA: Paean or Lament? |
title_full_unstemmed | Re: Aducanumab-Related ARIA: Paean or Lament? |
title_short | Re: Aducanumab-Related ARIA: Paean or Lament? |
title_sort | re: aducanumab-related aria: paean or lament? |
topic | Letter to the Editor |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10184812/ https://www.ncbi.nlm.nih.gov/pubmed/36724162 http://dx.doi.org/10.1097/RLU.0000000000004509 |
work_keys_str_mv | AT høilundcarlsenpoulf readucanumabrelatedariapaeanorlament AT alaviabass readucanumabrelatedariapaeanorlament AT revheimmonaelisabeth readucanumabrelatedariapaeanorlament |